Timothy S. Nelson, President and CEO at MAP Pharmaceuticals, Inc. (MAPP), sold 20,000 shares at $14.50 ($290K) on 2011-12-20, disclosed to the SEC on 2011-12-22.
Scheduled sale ($290k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.50 | 13,362 | $194K | 66.8% |
| 2 | $14.52 | 6,638 | $96K | 33.2% |
| Total | $14.51 avg | 20,000 | $290K | 100% |
| Filing → |
| MAPP | SELL | 2010-07-02 | $182K | — | Filing → |
| MAPP | SELL | 2010-06-03 | $432K | — | Filing → |
| MAPP | SELL | 2010-05-14 | $513K | — | Filing → |